Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rujuan Xin"'
Autor:
Ying Li, Zongguang Tai, Jinyuan Ma, Fengze Miao, Rujuan Xin, Cuie Shen, Min Shen, Quangang Zhu, Zhongjian Chen
Publikováno v:
Journal of Nanobiotechnology, Vol 21, Iss 1, Pp 1-18 (2023)
Abstract Background Topical anticancer drugs offer a potential therapeutic modality with high compliance for treating cutaneous squamous cell carcinoma (cSCC). However, the existing topical treatments for cSCC are associated with limited penetrating
Externí odkaz:
https://doaj.org/article/2f1456dcda82457588f083fe6622f9cf
Autor:
Xiaolong Li, Fengze Miao, Rujuan Xin, Zongguang Tai, Huijun Pan, Hao Huang, Junxia Yu, Zhongjian Chen, Quangang Zhu
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundFufang Honghua Buji (FHB) granules, have proven efficacy against vitiligo in long-term clinical practice. However, its major active chemical components and molecular mechanisms of action remain unknown. The purpose of this study was to conf
Externí odkaz:
https://doaj.org/article/a020943d783f489aad9237715ed9477e
Publikováno v:
Frontiers in Physiology, Vol 11 (2020)
Xanomeline, a muscarinic acetylcholine receptor agonist, is one of the first compounds that was found to be effective in the treatment of schizophrenics and attenuating behavioral disturbances of patients with Alzheimer’s disease (AD). However, its
Externí odkaz:
https://doaj.org/article/c97c06f7ace34aa38d41886889e7bcf4
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 112, Iss , Pp - (2019)
Microvascular and macrovascular complications are major causes of disability and death in diabetic patients. High levels of blood glucose sabotage the integrity of blood vessels and induce endothelial dysfunction. Fenofibrate is an agonist of peroxis
Externí odkaz:
https://doaj.org/article/ec836180ad4241468d68066317fa38e6
Autor:
Hao Huang, Rujuan Xin, Xiaolong Li, Xinyue Zhang, Zhongjian Chen, Quangang Zhu, Zongguang Tai, Leilei Bao
Publikováno v:
International Wound Journal.